Fig. 9.

Clinical implications of ZHRRS for practical applications. A Different distributions of clinicopathologic features in ZHRRS-high group and ZHRRS-low group. B Correlations between ZHRRS and immune cell levels in the training and validation cohorts. C Prognostic values of ZHRRS in pan-tumor (clinical endpoints: DSS, OS, and PFI). D-E Associations between ZHRRS, clinicopathologic characteristics and DFS in the D univariable and E multivariable Cox analysis. F Integrated nomogram for PCa prognosis prediction. G-I Calibration curves of the established nomogram in G 1-, H 3-, and I 5-year